Filing Details

Accession Number:
0001209191-14-039384
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-05 18:09:40
Reporting Period:
2014-06-04
Filing Date:
2014-06-05
Accepted Time:
2014-06-05 18:09:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1206199 G Daniel Welch 3280 Bayshore Blvd
Brisbane CA 94005
Chairman, Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-06-04 3,914 $39.19 94,202 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares sold in this transaction were acquired pursuant to a restricted stock unit grant and were sold pursuant to a pre-existing order to sell that number of shares necessary to cover the taxes owed upon the vesting of such restricted stock unit.
  2. Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $39.19 to $39.23 per share. Full information on the numbers of shares sold at each sale price is available upon request.